What do parents want for their children who are overweight when visiting the paediatrician?

C Upperman1, P Palmieri2, H Lin3

  • 1School of Medicine, UT Southwestern Medical Center, Dallas, TX, USA.

Insights

Parental preferences for pediatric weight management vary by child

Area of Science:

  • Pediatric primary care
  • Obesity prevention and management
  • Health behavior research

Background:

  • Childhood obesity is a significant public health concern.
  • Effective weight management requires understanding parental perspectives.
  • Primary care settings are crucial for addressing pediatric overweight.

Purpose of the Study:

  • To investigate how parental preferences for weight management strategies differ based on child's age, gender, weight status severity, race/ethnicity, and parental agreement on the child being overweight.
  • To identify factors influencing parental views on the helpfulness of child presence during weight discussions and dietary advice preferences.

Main Methods:

  • A survey was administered to parents of 2- to 18-year-old children diagnosed with overweight at an academic primary care clinic.
  • Data collected included parental perception of child overweight, views on child presence during weight discussions, and dietary advice preferences.
  • Multivariable analyses were performed to identify characteristics associated with preferred weight management strategies.

Main Results:

  • A majority of parents found child presence during weight discussions helpful (83%) and preferred paediatricians to prescribe specific diets (74%).
  • Older child age, male gender, and obesity (vs. overweight) were associated with parents finding child presence more helpful.
  • Latino ethnicity, older child age, and parental agreement on the child being overweight were associated with preferences for specific dietary advice.

Conclusions:

  • Parental preferences for pediatric weight management strategies are influenced by various child and family characteristics.
  • Tailoring weight management approaches to individual child demographics and parental perceptions may enhance effectiveness.
  • Further research into culturally sensitive and age-appropriate interventions is warranted.
Abstract

Related Concept Videos

Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
316
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.4K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
392
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
434
Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
1.7K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
338